Growing community of inventors

Tres Cantos-Madrid, Spain

Manuel Ángel González De La Peña

Average Co-Inventor Count = 5.00

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

Manuel Ángel González De La PeñaRosa Ana García Castro (3 patents)Manuel Ángel González De La PeñaDamián García Olmo (3 patents)Manuel Ángel González De La PeñaMaría Gema Fernández Miguel (3 patents)Manuel Ángel González De La PeñaMariano García Arranz (3 patents)Manuel Ángel González De La PeñaManuel Ángel González De La Peña (3 patents)Rosa Ana García CastroRosa Ana García Castro (6 patents)Damián García OlmoDamián García Olmo (6 patents)María Gema Fernández MiguelMaría Gema Fernández Miguel (6 patents)Mariano García ArranzMariano García Arranz (6 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Universidad Autónoma De Madrid (3 from 30 patents)

2. Tigenix, S.a.u. (2 from 12 patents)

3. Takeda Pharmaceutical Company Limited (1 from 1,178 patents)


3 patents:

1. 11672831 - Use of adipose tissue-derived stromal stem cells in treating fistula

2. 10780132 - Use of adipose tissue-derived stromal stem cells in treating fistula

3. 10758575 - Use of adipose tissue-derived stromal stem cells in treating fistula

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/18/2025
Loading…